Literature DB >> 11146694

Anaphylaxis in the United States: an investigation into its epidemiology.

A I Neugut1, A T Ghatak, R L Miller.   

Abstract

BACKGROUND: Anaphylaxis is a severe, life-threatening allergic reaction that affects both children and adults in the United States. However, data regarding the incidence and prevalence of anaphylaxis and the number of deaths caused by it are limited.
OBJECTIVE: To provide a better understanding of the magnitude of the problem of anaphylaxis in the United States.
METHODS: A thorough review of the current medical literature was conducted to obtain prevalence estimates on each of the 4 major subtypes of anaphylaxis (food, drugs, latex, and insect stings). We calculated an overall estimate of the risk of anaphylaxis by using only estimates that are specifically derived from epidemiologic studies measuring anaphylaxis in the general population.
RESULTS: Known rates or cases of anaphylaxis were 0.0004% for food, 0.7% to 10% for penicillin, 0. 22% to 1% for radiocontrast media, and 0.5% to 5% after insect stings. There were 220 cases after latex exposure. Considering the 1999 US population of 272 million, the population at risk for anaphylaxis from food is 1099, from penicillin is 1.9 million to 27. 2 million, from radiocontrast media is 22 000 to 100 000, from latex is 220, and from insect stings is 1.36 million to 13.6 million. These calculations yield a total of 3.29 million to 40.9 million individuals at risk of anaphylaxis.
CONCLUSION: The occurrence of anaphylaxis in the US is not as rare as is generally believed. On the basis of our figures, the problem of anaphylaxis may, in fact, affect 1.21% to 15.04% of the US population.

Entities:  

Mesh:

Year:  2001        PMID: 11146694     DOI: 10.1001/archinte.161.1.15

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  64 in total

Review 1.  Adrenaline in the treatment of anaphylaxis: what is the evidence?

Authors:  Andrew P C McLean-Tooke; Claire A Bethune; Ann C Fay; Gavin P Spickett
Journal:  BMJ       Date:  2003-12-06

2.  Food-induced anaphylaxis.

Authors:  Antonella Cianferoni; Antonella Muraro
Journal:  Immunol Allergy Clin North Am       Date:  2011-11-21       Impact factor: 3.479

Review 3.  Antibiotic desensitization therapy in secondary syphilis and Listeria infection: case reports and review of desensitization therapy.

Authors:  Gil Magpantay; Anthony P Cardile; Cristian S Madar; Gunther Hsue; Conrad Belnap
Journal:  Hawaii Med J       Date:  2011-12

4.  Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.

Authors:  Beatrix Schäfer; Adrian M Piliponsky; Tatsuya Oka; Chang Ho Song; Norma P Gerard; Craig Gerard; Mindy Tsai; Janet Kalesnikoff; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2012-06-22       Impact factor: 10.793

Review 5.  Diet and dermatitis: food triggers.

Authors:  Rajani Katta; Megan Schlichte
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

Review 6.  Latitude, sunlight, vitamin D, and childhood food allergy/anaphylaxis.

Authors:  Raymond James Mullins; Carlos A Camargo
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

7.  Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.

Authors:  Roberto Leone; Anita Conforti; Mauro Venegoni; Domenico Motola; Ugo Moretti; Ilaria Meneghelli; Alfredo Cocci; Giulia Sangiorgi Cellini; Stefania Scotto; Nicola Montanaro; Giampaolo Velo
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 8.  H1-antihistamines for the treatment of anaphylaxis with and without shock.

Authors:  A Sheikh; V m ten Broek; S G A Brown; F E R Simons
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 9.  [Anaphylaxis. Clinical manifestations and diagnosis].

Authors:  B Przybilla; J Ring; F Ruëff
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

10.  Documentation of drug allergy on drug chart in patients presenting for surgery.

Authors:  M Farooq; C Kirke; K Foley
Journal:  Ir J Med Sci       Date:  2008-06-17       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.